Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.
作者信息
Lopez Dupla M, Gil Aguado A, Lavilla Uriol P, Pintado Garcia V, Valencia Ortega E, Martinez Martinez P, Garcia-Puig J
出版信息
J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657.
PMID:8288512
Abstract
摘要
相似文献
1
Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.脂质体两性霉素B治疗和二级预防HIV感染患者内脏利什曼病的疗效：两例报告
J Antimicrob Chemother. 1993 Oct;32(4):657-9. doi: 10.1093/jac/32.4.657.
2
Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.间歇性脂质体两性霉素B治疗人类免疫缺陷病毒感染患者内脏利什曼病的疗效
Clin Infect Dis. 1995 Sep;21(3):711-2. doi: 10.1093/clinids/21.3.711.
3
Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.脂质体两性霉素B治疗合并人类免疫缺陷病毒感染患者内脏利什曼病的疗效
Clin Infect Dis. 1995 Jan;20(1):191. doi: 10.1093/clinids/20.1.191.
4
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.脂质体两性霉素B成功治疗感染人类免疫缺陷病毒患者的耐锑内脏利什曼病。
Clin Infect Dis. 1993 Oct;17(4):625-7. doi: 10.1093/clinids/17.4.625.
5
Liposomal amphotericin B as first line and secondary prophylactic treatment for visceral leishmaniasis in a patient infected with HIV.脂质体两性霉素B作为一名感染HIV患者内脏利什曼病的一线及二线预防性治疗药物。
Ann Ital Med Int. 2000 Apr-Jun;15(2):169-71.
6
Liposomal amphotericin B for the treatment of visceral leishmaniasis.脂质体两性霉素B用于治疗内脏利什曼病。
Clin Infect Dis. 2006 Oct 1;43(7):917-24. doi: 10.1086/507530. Epub 2006 Aug 28.
7
8
Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.关于《脂质体两性霉素B对HIV感染患者内脏利什曼病二级预防的疗效》的评论
J Antimicrob Chemother. 2008 Feb;61(2):466-7; author reply 467. doi: 10.1093/jac/dkm478. Epub 2007 Dec 11.
9
Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome).HIV感染患者的内脏利什曼病：高剂量脂质体两性霉素B（安必素）治疗
J Infect. 1996 Mar;32(2):133-7. doi: 10.1016/s0163-4453(96)91343-2.
10
[Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)].[与人类免疫缺陷病毒感染相关的内脏利什曼病（回复）]
Enferm Infecc Microbiol Clin. 2002 Mar;20(3):133. doi: 10.1016/s0213-005x(02)72766-3.
引用本文的文献
1
Leishmania and human immunodeficiency virus coinfection: the first 10 years.利什曼原虫与人类免疫缺陷病毒合并感染：头十年
Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298.
2
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.婴儿利什曼原虫所致内脏利什曼病的治疗：两性霉素B脂质体疗效的实验评估
Antimicrob Agents Chemother. 1996 May;40(5):1214-8. doi: 10.1128/AAC.40.5.1214.
Zotero 插件